Open Access Repository

Echocardiographic evaluation of cardiac function after cancer chemotherapy

Negishi, T and Negishi, K ORCID: 0000-0002-9086-2565 2017 , 'Echocardiographic evaluation of cardiac function after cancer chemotherapy' , Journal of Echocardiography , pp. 1-8 , doi: 10.1007/s12574-017-0344-6.

Full text not available from this repository.


Progress in cancer therapy has led to improved prognosis of patients with cancer and thus to a continuous rise of cancer survivors. However, it has simultaneously increased cardiovascular morbidity and mortality rates due to direct and/or indirect side effects of anticancer treatment. Similar to the rapid rise of patients with adult congenital disease, the number of patients suffering or at risk of cardiotoxicity has been steeply increasing and getting an emerging issue. Among the many facets of chemotherapy-induced cardiovascular toxicity, this review attempts to summarize echocardiographic evaluation of cardiac function after cancer chemotherapy by reviewing the definition, risk factors, brief history, limitation of left ventricular ejection fraction and myocardial strain imaging, as well as the limitations of this technique.

Item Type: Article
Authors/Creators:Negishi, T and Negishi, K
Keywords: anthracycline, cancer therapy-related cardiac dysfunction, cardiotoxicity, ejection fraction, myocardial strain, trastuzumab
Journal or Publication Title: Journal of Echocardiography
Publisher: Springer Japan KK
ISSN: 1349-0222
DOI / ID Number: 10.1007/s12574-017-0344-6
Copyright Information:

© Japanese Society of Echocardiography 2017

Related URLs:
Item Statistics: View statistics for this item

Actions (login required)

Item Control Page Item Control Page